Skip to main content
. 2017 Mar 27;37(5):2575–2582. doi: 10.3892/or.2017.5530

Figure 1.

Figure 1.

SLC3A2 expression is upregulated in OS clinical samples and cell lines. (A and B) The mRNA and protein expression levels of SLC3A2 were measured by TaqMan real-time PCR and western blot assays in OS cell lines (including MNNG/HOS, MG63 and U2OS) and a human osteoblastic cell line (hFOB). (C and D) Relative expression of SLC3A2 was detected using qRT-PCR in 20 pairs of OS samples and their corresponding non-cancerous samples. Statistical analysis was performed using paired t-test in C.